SPHERA FUNDS MANAGEMENT LTD.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1496201 TEL AVIV, L3

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,824,312

+$1,983,269 QoQ

Shares Held

926,004

+255.6% QoQ

Ownership

0.891%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#21

of 162 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. LRMR ranks #54 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,469,971	$39,659,817
2	SNDX	Syndax Pharmaceuticals Inc	1,014,606	$22,179,287
3	RARE	Ultragenyx Pharmaceutical Inc.	588,494	$19,649,814
4	BMRN	Biomarin Pharmaceutical Inc	328,550	$18,799,631
5	CYTK	Cytokinetics Inc	219,987	$18,740,692
6	BBIO	BridgeBio Pharma, Inc.	245,346	$18,273,370
7	COGT	Cogent Biosciences, Inc.	459,340	$17,776,458
8	INSM	INSMED Inc	118,800	$12,666,456

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,824,312	926,004	+255.6%	Shares	Defined	2026-08-14
2025-09-30	$841,043	260,385	+32.4%	Shares	Defined	2025-11-14
2025-06-30	$568,275	196,635	-46.3%	Shares	Defined	2025-08-14
2025-03-31	$787,553	366,304	-19.6%	Shares	Defined	2025-05-15
2024-12-31	$1,763,187	455,604	+9.9%	Shares	Defined	2025-02-14
2024-09-30	$2,714,830	414,478	+32.6%	Shares	Defined	2024-11-14
2024-06-30	$2,265,400	312,469	+212.5%	Shares	Defined	2024-08-14
2021-03-31	$1,461,000	100,000	-70.8%	Shares	Defined	2021-05-17
2020-09-30	$5,189,110	342,064	-13.8%	Shares	Defined	2020-11-12
2020-06-30	$5,098,712	396,787	—	Shares	Defined	2020-08-13
No filing history on record for this holder in this stock.